Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

By Ijaz M.K.   Alkarmi T.O.   El-Mekki A.W.   Galadari S.H.I.   Dar F.K.   Babiuk L.A.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 331-338

Elsevier

Access to resources Recommend Favorite

Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK

By Hoshino Y.   Jones R.W.   Chanock R.M.   Kapikian A.Z.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3576-3584

Elsevier

Access to resources Recommend Favorite

Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines

By Bastien N.   Trudel M.   Simard C.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 832-836

Elsevier

Access to resources Recommend Favorite

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles

By Jiang B.   Estes M.K.   Barone C.   Barniak V.   O'Neal C.M.   Ottaiano A.   Madore H.P.   Conner M.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 1005-1013

Elsevier

Access to resources Recommend Favorite

Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo

By Thapliyal R.   Maru G.B.  

Food and Chemical Toxicology, Vol. 39, Iss. 6, 2001-06 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite